Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate 18F-N230A PET/CT Imaging of Nectin-4 Expression in Patients With Renal Cell Carcinoma and Renal Pelvic Urothelial Carcinoma

NCT07875959 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT07875959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07875959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate 18F-N230A PET/CT Imaging of Nectin-4 Expression in Patients With Renal Cell Carcinoma and Renal Pelvic Urothelial Carcinoma
Lead sponsor
Peking University First Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
July 9, 2026
Completion date
December 31, 2028
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma (rcc), renal pelvic urothelial carcinoma